(Press-News.org) Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive problems after surgery, according to a new study by researchers at Imperial College London and University of California, San Francisco (UCSF).
The research also reveals for the first time that a specific inflammatory response in the brain may explain why many patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness.
The findings, from research in mouse models, could lead to human clinical trials within a year, the authors say. Their work is published today in the journal Proceedings of the National Academy of Sciences.
For years, anesthesiologists and neurologists have struggled to explain why some patients, especially the elderly, experience confusion, learning disorders and memory loss after surgery – a condition clinicians call post-operative cognitive decline. While typically short-term, this delirium occurs widely in intensive care units, affecting between 28 and 92 per cent of hospitalized patients, depending on their age, health status and type of surgery. It also has been linked to poorer surgical outcomes, as well as an increased risk of mortality, inability to cope and possible permanent dementia.
Until now, researchers have not clearly understood what causes the disorder or how to treat it. The new research suggests that it is caused by cell-to-cell signalling molecules called cytokines released by cells of the immune system. There are drugs already in use that target the activity of cytokines so it is possible that these drugs could be effective against cognitive decline.
The senior author of the study is Mervyn Maze, MB ChB, Professor and Chair of the Department of Anesthesiology and Perioperative Care at UCSF and a Visiting Professor in the Department of Surgery and Cancer at Imperial College London.
"Antibody therapies already are widely used against cytokines to prevent or treat inflammation, so we know that these are effective in humans," said Professor Maze, who began the research at Imperial before moving to UCSF. "This study suggests that one day we also might be able to use these therapies as a single, pre-surgical dose to prevent cognitive decline in susceptible patients."
Previous studies have linked post-operative cognitive decline with the rise in blood levels of a cytokine called interleukin-1 beta (IL-1β), which is involved in inflammation. For this study, Maze and his colleagues studied another cytokine called tumour necrosis factor (TNF-α), which is known to regulate the immune system's inflammatory response before interleukin-1 is produced.
Working with Professor Sir Marc Feldmann – a pioneer in cytokine research in inflammatory disorders and Head of the Kennedy Institute of Rheumatology at Imperial College London – the team gave a single dose of anti-TNF antibody to mice before giving them surgery. They found that the treatment decreased blood levels of IL-1β, limited inflammation in the brain and prevented the mice from showing behavioural signs of cognitive decline.
The research suggests that TNF acts "upstream" of IL-1 and triggers a cascade of immune responses during surgery that provokes the production of IL-1 in the brain, Professor Maze said. That in turn contributes to cognitive decline after surgery or critical illness.
"This is an important observation, as it demonstrates that cytokines are potential therapeutic targets in a wider range of diseases, not just autoimmune disease and cancer for which they are known targets," Professor Feldmann said. "Moreover, effective therapeutics already are available, with a known safety profile and modest cost if used short term."
INFORMATION:
The study was supported by the Westminster Medical School Research Trust, in London, the Mathilda and Terence Kennedy Institute of Rheumatology Trust, and Arthritis Research UK.
Arthritis Research UK-funded research at its Kennedy Institute of Rheumatology was instrumental in showing the substantial health benefits of anti-TNF therapy in patients with rheumatoid arthritis and has transformed the lives of millions of people worldwide. Medical director of the charity Professor Alan Silman said: "This research shows the potential that these drugs have in other areas of health."
For further information please contact:
Sam Wong
Research Media Officer
Imperial College London
Email: sam.wong@imperial.ac.uk
Tel: +44(0)20 7594 2198
Out of hours duty press officer: +44(0)7803 886 248
Notes to editors:
1. Journal reference
N Terrando et al. Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline. Proceedings of the National Academy of Sciences, 1 November 2010.
A copy of the paper can be downloaded from
https://fileexchange.imperial.ac.uk/files/e0d383fa682/pnas201014557_pvqearNT11.13.pdf
2. About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.
In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.
Website: www.imperial.ac.uk
3. About University of California, San Francisco
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
Website: www.ucsf.edu.
4. About Arthritis Research UK
Arthritis Research UK is the leading authority on arthritis in the UK, conducting scientific and medical research into all types of arthritis and musculoskeletal conditions. It is the UK's fourth largest medical research charity and the only charity solely committed to funding high quality research into the cause, treatment and cure of arthritis.
Website: www.arthritisresearchuk.org
5. About the Mathilda and Terence Kennedy Institute of Rheumatology Trust
The Mathilda and Terence Kennedy Institute of Rheumatology Trust (the KIR Trust) was founded in 1965/66. It is committed to supporting research into rheumatism and allied diseases which it does by means of grants.
Website www.kirtrust.org
Arthritis drugs could help prevent memory loss after surgery, study suggests
2010-11-02
ELSE PRESS RELEASES FROM THIS DATE:
Quantum computing with braids in flatland
2010-11-02
When confined to a 2-dimensional sheet, some exotic particle-like structures known as anyons appear to entwine in ways that could lead to robust quantum computing schemes, according to research appearing in the November 1 issue of the journal Physical Review B. The physicists at Bell Laboratories who performed the research are hopeful the anyons can be induced to follow paths that twist into braids that would be much more resistant to disturbances that corrupt data and calculations in quantum computers relying on individual particles.
The anyons the researchers believe ...
Virginia Tech computer scientist, student design award winning software to combat hacking
2010-11-02
One of the serious threats to a user's computer is a software program that might cause unwanted keystroke sequences to occur in order to hack someone's identity. This form of an attack is increasing, infecting enterprise and personal computers, and caused by "organized malicious botnets," said Daphne Yao, assistant professor of computer science at Virginia Tech (http://www.cs.vt.edu/user/115).
To combat the "spoofing attacks," Yao and her former student, Deian Stefan, now a graduate student in the computer science department at Stanford University, developed an authentication ...
Typists' errors and intention theories
2010-11-02
New research published today in the journal Science says people think about things they think they don't think about. Vanderbilt University psychologists Gordon Logan and Matthew Crump say when highly skilled people such as surgeons, carpenters, or pilots perform actions without thinking, those actions are highly controlled. The finding adds key information to a debate on whether people consciously perform actions in which they are highly skilled.
Previous research suggests conscious control of driving a car for an experienced driver, for example, is an illusion. These ...
Race may influence uterine cancer recurrence, despite treatment
2010-11-02
DETROIT – African Americans are more likely to have a recurrence of uterine cancer despite undergoing a total hysterectomy or a hysterectomy followed by radiation therapy, according to researchers at Henry Ford Hospital in Detroit.
"The African American patients in our study had similar surgeries and radiation therapy as the Caucasian patients in the study. So access to care certainly wasn't a factor in race being identified as a negative predictor for outcome," says lead author Mohamed Elshaikh, M.D., senior staff physician in the Department of Radiation Oncology at ...
NPL builds long range alpha detector
2010-11-02
The UK's National Physical Laboratory (NPL) has developed a new portable radiation detector that can assess the safety of potentially contaminated areas far quicker than current methods. The prototype was inspired by the aftermath of the murder of Alexander Litvinenko in London 2006.
Litvinenko's death was due to radiation poisoning from polonium-210. It prompted wide-scale work to assess radiation levels at almost 50 premises in London that he had been prior to his death before opening them up again to the public, costing the Health Protection Agency £2 million.
The ...
Pivoting hooks of graphene's chemical cousin could revolutionize work of electron microscopes
2010-11-02
The single layer material Graphene was the subject of a Nobel prize this year but research led by a team of researchers at the University of Warwick has found molecular hooks on the surface of its close chemical cousin, Graphene Oxide, that will potentially provide massive benefits to researchers using transmission electron microscopes. They could even be used in building molecular scale mechanisms.
The research team, which includes Drs. Jeremy Sloan, Neil Wilson and PhD student Priyanka Pandey from the Department of Physics and Dr. Jon Rourke from the Department of Chemistry ...
New strain of 'high-runner' rats uniquely resistant to disease -- all disease!
2010-11-02
Everybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models. A new research paper published in the November 2010 print issue of The FASEB Journal (http://www.faseb.org) started out as a study to explain the strong statistical link between low aerobic exercise capacity and common diseases, but ultimately led to an animal model ...
Scientists turn a new leaf to discover a compound in daffodils that targets brain cancer
2010-11-02
When looking for new ways to treat aggressive brain cancers, an international team of scientists turned a new leaf and "discovered" the lowly daffodil. A new research study published in the November 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers hope that a natural compound found in daffodil bulbs, called narciclasine, may be a powerful therapeutic against biologically aggressive forms of human brain cancers.
"We are planning to move a narciclasine derivative toward clinical trials in oncology within a three to four year period in order to help patients ...
Scientists uncover a genetic switch that turns immune responses on and off
2010-11-02
Scientists are keeping their eye on a new discovery published in the November 2011 print issue of the FASEB Journal (http://www.fasebj.org) that explains what causes some genes to go out of control. Scientists have identified a "cellular switch," called eye transformer, that controls the flow of information from chemical signals outside of the cell to genes in the cell nucleus. This study demonstrates that when eye transformer is turned off, the information pathway it controls (the "JAK/STAT pathway") hyper-activates. Because this pathway exists in humans and is involved ...
Mayo researchers find mortality rates from liver diseases underestimated
2010-11-02
ROCHESTER, Minn. -- Statistics from the Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/) rank mortality related to chronic liver disease and cirrhosis as the 12th most common cause of death in adults in the U.S. Using a modified definition that includes diseases such as viral hepatitis, liver cancer (http://www.mayoclinic.org/liver-cancer/) and obesity-related fatty liver disease (liver diseases)(http://www.mayoclinic.org/liver-disease/), Mayo Clinic-led researchers have found that liver-related mortality is as high as fourth for some age groups, and ...